PhD thesis in the field of bioprocess engineering. Main focus on the process intensification of cell culture based vaccines and viral vectors. Initial focus on oncolytic viruses.

High cell-density production of recombinant filovirus vaccines in Drosophila S2 insect cells.

BioPharma Global, a non-profit-operating corporation based in the Washington D.C. metro area, offers FDA & EMA regulatory affairs and a complete suite of professional services to address the needs of emerging and growing biotech companies globally dedicated to rare disease research. We are a full-service FDA and EMA regulatory affairs firm specializing in orphan drugs, medical devices/diagnostics, and diseases with high unmet medical needs, providing support for meetings with the agency, IND Filings, and other expedited programs.

Process intensification of cell-culture based MVA productionPerfusion cultivations (ATF, acoustic settler)Virus dynamics (e.g. capacitance probe)

- social media and digital media design- marketing

- Department “Fermentation and Purification”- Preparing, performing and evaluating tests relating to the development of bioreactors to cultivate mammalian cells- Optimizing cultivation conditions in respect of cell retention in parallelized continuous bioreactors